A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2653 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2018-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer

NCT03413956

Non Small Cell Lung Cancer

COMPLETED

A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer

NCT03451526

Non-small Cell Lung Cancer

COMPLETED

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

NCT03427541

Non Small Cell Lung Cancer

UNKNOWN

A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

NCT03427567

Non-small Cell Lung Cancer

COMPLETED

A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies

NCT03421093

Lung Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

N2 non-small cell lung cancer

Chinese patients with N2 non-small cell lung cancer

Surgery

Intervention Type PROCEDURE

Surgeries plus dissection of lymph nodes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery

Surgeries plus dissection of lymph nodes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with surgeries from 2014 to 2017;
* Pathologically diagnosed patients with non-small cell lung cancer;
* Age \> 18 years old;
* Patients with chest surgeries before hospitalization;
* Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group 10 and 11 lymph nodes);